Weiss M, Shaeffer Z, Eisenstein Z
Department of Medicine, Chaim Sheba Medical Center, Tel Hashomer, Israel.
South Med J. 1990 Nov;83(11):1315-7. doi: 10.1097/00007611-199011000-00023.
Orthostatic hypotension of the Shy-Drager syndrome is a chronic incapacitating condition characterized by lack of an appropriate increase in the plasma norepinephrine level in response to standing. Recently, the somatostatin analogue octreotide has been reported to induce a pressor response in patients having this syndrome. We have reported a case of Shy-Drager syndrome in which octreotide was effective, but the rise in blood pressure was not accompanied by an increase in the plasma norepinephrine level. Hence, the pressor effect of octreotide is not mediated by stimulation of the sympathetic nervous system, but probably through splanchnic vasoconstriction.
夏伊-德雷格综合征的直立性低血压是一种慢性致残病症,其特征为站立时血浆去甲肾上腺素水平缺乏适当升高。最近,有报道称生长抑素类似物奥曲肽可在患有该综合征的患者中诱发升压反应。我们报告了一例夏伊-德雷格综合征病例,其中奥曲肽有效,但血压升高并未伴随血浆去甲肾上腺素水平升高。因此,奥曲肽的升压作用不是由交感神经系统刺激介导的,而可能是通过内脏血管收缩实现的。